» Articles » PMID: 24398917

Ultrasonography Survey and Thyroid Cancer in the Fukushima Prefecture

Overview
Date 2014 Jan 9
PMID 24398917
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Thyroid cancer is one of the major health concerns after the accident in the Fukushima Dai-ichi nuclear power station (NPS). Currently, ultrasonography surveys are being performed for persons residing in the Fukushima Prefecture at the time of the accident with an age of up to 18 years. Here, the expected thyroid cancer prevalence in the Fukushima Prefecture is assessed based on an ultrasonography survey of Ukrainians, who were exposed at an age of up to 18 years to (131)I released during the Chernobyl NPS accident, and on differences in equipment and study protocol in the two surveys. Radiation risk of thyroid cancer incidence among survivors of the atomic bombings of Hiroshima and Nagasaki and preliminary estimates of thyroid dose due to the Fukushima accident were used for the prediction of baseline and radiation-related thyroid cancer risks. We estimate a prevalence of thyroid cancer of 0.027 % (95 % CI 0.010 %; 0.050 %) for the first screening campaign in the Fukushima Prefecture. Compared with the incidence rate in Japan in 2007, the ultrasonography survey is predicted to increase baseline thyroid cancer incidence by a factor of 7.4 (95 % CI 0.95; 17.3). Under the condition of continued screening, thyroid cancer during the first fifty years after the accident is predicted to be detected for about 2 % of the screened population. The prediction of radiation-related thyroid cancer in the most exposed fraction (a few ten thousand persons) of the screened population of the Fukushima Prefecture has a large uncertainty with the best estimates of the average risk of 0.1-0.3 %, depending on average dose.

Citing Articles

ProZES: the methodology and software tool for assessment of assigned share of radiation in probability of cancer occurrence.

Ulanowski A, Shemiakina E, Guthlin D, Becker J, Preston D, Apostoaei A Radiat Environ Biophys. 2020; 59(4):601-629.

PMID: 32851496 PMC: 7544726. DOI: 10.1007/s00411-020-00866-7.


Risk bases can complement dose bases for implementing and optimising a radiological protection strategy in urgent and transition emergency phases.

Walsh L, Ulanowski A, Kaiser J, Woda C, Raskob W Radiat Environ Biophys. 2019; 58(4):539-552.

PMID: 31346699 PMC: 6768908. DOI: 10.1007/s00411-019-00809-x.


Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment.

Kaiser J, Meckbach R, Eidemuller M, Selmansberger M, Unger K, Shpak V Carcinogenesis. 2016; 37(12):1152-1160.

PMID: 27729373 PMC: 5137265. DOI: 10.1093/carcin/bgw102.


Can screening effects explain increased risk of thyroid cancer among population living near nuclear power plants in Korea?.

Lee W Environ Health Toxicol. 2016; 30:e2015013.

PMID: 26796892 PMC: 4722967. DOI: 10.5620/eht.e2015013.


Quantification of the increase in thyroid cancer prevalence in Fukushima after the nuclear disaster in 2011--a potential overdiagnosis?.

Katanoda K, Kamo K, Tsugane S Jpn J Clin Oncol. 2016; 46(3):284-6.

PMID: 26755830 PMC: 4777612. DOI: 10.1093/jjco/hyv191.


References
1.
Jacob P, Ruhm W, Walsh L, Blettner M, Hammer G, Zeeb H . Is cancer risk of radiation workers larger than expected?. Occup Environ Med. 2009; 66(12):789-96. PMC: 2776242. DOI: 10.1136/oem.2008.043265. View

2.
Veiga L, Lubin J, Anderson H, De Vathaire F, Tucker M, Bhatti P . A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res. 2012; 178(4):365-76. PMC: 3488851. DOI: 10.1667/rr2889.1. View

3.
Ron E, Lubin J, Shore R, Mabuchi K, Modan B, Pottern L . Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995; 141(3):259-77. View

4.
Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V . Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 2005; 97(10):724-32. DOI: 10.1093/jnci/dji129. View

5.
Delides G, Elemenoglou J, Lekkas J, Kittas C, Evthimiou C . Occult thyroid carcinoma in a Greek population. Neoplasma. 1987; 34(1):119-25. View